Paper34838239
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.
Teunissen CE and 8 others. Lancet Neurol, 2022. Cited by 847 papers, by iCite.
Cite this record
ConductScience Library. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. Papers, record 34838239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34838239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Amyloid beta-Peptides | |
| Biomarkers | |
| Disease Progression | |
| Humans | |
| tau Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 AG006786 | NIA NIH HHS | United States | U01AG006786 | PubMed and NIH | NIH RePORTER |
| P30 AG062677 | NIA NIH HHS | United States | P30AG062677 | PubMed and NIH | NIH RePORTER |
| U54 AG044170 | NIA NIH HHS | United States | U54AG044170 | PubMed and NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05604183 | Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease | Background | ClinicalTrials.gov | |
| NCT07917182 | Chinese University-Alzheimer's Disease With Vascular and Other Co-pathology: Towards Actionable Neuro-Cognitive-Omic Evaluations (CU-ADVANCE) | Background | ClinicalTrials.gov |
Cited by661
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 847 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42989187 | Construction of an auxiliary diagnostic model for Alzheimer's disease based on routine peripheral blood parameters. | BMC Psychiatry | 2026 | https://conductscience.org/library/papers/42989187 | PubMed |
| 42967588 | Chronic kidney disease and blood-based biomarkers of Alzheimer's disease: the brain in kidney disease study. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42967588 | PubMed |
| 42954299 | A general practice-centred model for early diagnosis and management of Alzheimer's disease in Denmark: rationale, evidence and a pragmatic diagnostic approach. | Scand J Prim Health Care | 2026 | https://conductscience.org/library/papers/42954299 | PubMed |
| 42949229 | The Target48 Neurodegeneration panel: A novel tool for profiling protein signatures in neurodegenerative disorders. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42949229 | PubMed |
| 42948155 | Perspectives on plasma biomarkers for point-of-care diagnostics in Alzheimer's disease: Insights into 2D-BioPAD. | J Alzheimers Dis Rep | 2026 | https://conductscience.org/library/papers/42948155 | PubMed |
| 42947286 | CSF and plasma lipid profiling predicts risk of cognitive impairment in cognitively unimpaired older adults. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42947286 | PubMed |
| 42947225 | Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42947225 | PubMed |
| 42926906 | Scalable Hydrogel Nanoparticle Enrichment for Enhanced Mass Spectrometry-based Proteomic Analysis of Plasma or Volumetric Dried Blood Samples. | Res Sq | 2026 | https://conductscience.org/library/papers/42926906 | PubMed |
| 42913444 | Blood-Based Biomarkers as Predictors of All-Cause Dementia: A 13-Year Follow-Up in the Whitehall II Cohort Study. | Neurology | 2026 | https://conductscience.org/library/papers/42913444 | PubMed |
| 42889489 | Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer's disease. | Brain Commun | 2026 | https://conductscience.org/library/papers/42889489 | PubMed |
| 42885984 | Multimodal Retinal Imaging Correlates With Brain Atrophy and Plasma Biomarkers in Alzheimer's Disease. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42885984 | PubMed |
| 42883821 | Plasma Neurofilament Light Chain as a Complementary Biomarker for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883821 | PubMed |
| 42877365 | Feasibility of digital multidomain cognitive testing in mild cognitive impairment and dementia assessment in primary care. | J Alzheimers Dis Rep | 2026 | https://conductscience.org/library/papers/42877365 | PubMed |
| 42871474 | Global research trends and hotspots in blood-based biomarkers for Alzheimer's disease: a bibliometric analysis. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42871474 | PubMed |
| 42859768 | ATRI LIMS: a cloud-native open-source laboratory information management system for biomarker-driven Alzheimer's disease clinical trials. | JAMIA Open | 2026 | https://conductscience.org/library/papers/42859768 | PubMed |
| 42855152 | Plasma p-tau217 as a biomarker for Alzheimer's disease: diagnostic and prognostic value in clinical and population-based studies. | Arq Neuropsiquiatr | 2026 | https://conductscience.org/library/papers/42855152 | PubMed |
| 42825863 | Combined Prognostic Value of Triglyceride-Glucose Index and Bilirubin in Drug-Eluting Stent Restenosis: From Clinical Risk Stratification to Exploratory Vascular-Cell Findings. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/42825863 | PubMed |
| 42823889 | Bayesian networks to estimate prognosis in vascular cognitive impairment and small vessel disease: Integrated analyses of interdependent contributors to multiple outcomes. | J Cereb Blood Flow Metab | 2026 | https://conductscience.org/library/papers/42823889 | PubMed |
| 42821845 | Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers. | Neurology | 2026 | https://conductscience.org/library/papers/42821845 | PubMed |
| 42818491 | MRI-derived periventricular diffusivity contextualizes plasma pTau217 associations with Alzheimer pathology: a discovery-validation study. | Res Sq | 2026 | https://conductscience.org/library/papers/42818491 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34838239
GET https://conductscience.org/api/papers/v1/34838239/cited_by?page=2